Glycopyrrolate Injection
Product Images NDC 71872-7094

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (3f3b363b Fe6d 4dee 89bd C2ca992dcf49 01)

Chemical structure of glycopyrrolate shown with its molecular formula C19H28BrNO3 and molecular weight 398.33.*

FDA Label Image

5 mL Vial Label (3f3b363b Fe6d 4dee 89bd C2ca992dcf49 06)

Label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) multi-dose vial. Indicates use for intramuscular or intravenous administration, contains benzyl alcohol preservative, and warns not for use in newborns. Manufactured by Vintac Limited for Somerset Therapeutics LLC. Includes storage instructions and barcode.*

FDA Label Image

Pdp (7094)

Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) in a 5 mL single-dose vial. Label indicates the vial contains benzyl alcohol preservative, is for intramuscular or intravenous administration, and is manufactured by Wintac Limited with repackaging and distribution by Medical Purchasing Solutions, LLC. Storage instructions specify 20°C to 25°C (68° to 77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.